. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value … was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that … value. Our results also suggest that the biotechnology regime changed and the Nobel Prize lost its luster as a signal of …

North American Industry Classification System (NAICS) as biotechnology firms to estimate several Fama-French three factor …In the current study we find that biotechnology firms are exposed to greater financial risk than other industries and … capital over the 1982-2005 time period were 16.25 percent for biotechnology firms. Of course, these average estimates obscure …

Population ecology models are elegant in form and adequate in describing aggregate data, but poor in telling stories …, such as intellectual human capital, can predict where and when biotechnology enterprises emerge and agglomerate. Density … more conjectural than empirically tenable. We argue and demonstrate for biotechnology that an alternative model based on …

In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …

.S. biotechnology enterprises during 1976-1989. Using a linked cross-section/time- series panel data set, we find that the timing and … structures. We believe biotechnology may be prototypical of the birth patterns in other innovative industries …